FDA Inspection 1255107 — Harry Earl Studdard, MD
The FDA completed an inspection of Harry Earl Studdard, MD on November 6, 2024 in Mobile, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 6, 2024
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Mobile, AL (United States)
Additional Details
Clinical Investigator (CI)